BLOOD FLOW MEASUREMENT DEVICES MARKET ANALYSIS

Blood Flow Measurement Devices Market Size and Trends

The Global Blood Flow Measurement Devices Market is estimated to be valued at USD 810.5 Mn in 2024 and is expected to reach USD 1,495.1 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.1% from 2024 to 2031.

To learn more about this report, Request sample copy

The blood flow measurement devices market is expected to witness a healthy growth over the forecast period. Key factors such as the rising geriatric population, increasing incidence of cardiovascular diseases, and growing preference for minimally invasive procedures are expected to boost the demand for blood flow measurement devices. Additionally, technological advancements in Doppler ultrasound systems for improved blood flow detection and assessment are further expected to propel the market growth during the forecast period. However, the high cost of advanced blood flow measurement devices may hamper market growth to some extent.

Increasing demand for non-invasive diagnostic procedures

The demand for non-invasive diagnostic procedures has been increasing significantly over the past decade owing to various factors. The major reason behind this has been the increasing awareness among patients regarding the risks and discomfort associated with invasive diagnostic tests. Procedures like angiography or angioplasty which involves inserting tubes inside blood vessels through small incisions can cause complications like bleeding or infection in some cases. They also require hospitalization of the patient which further increases the medical costs. On the other hand, technologies available for non-invasive blood flow measurement provide reliable diagnostic information without causing any harm to the patient's body. Devices like Doppler ultrasound systems and laser Doppler flowmeters can measure blood flow, volume, and velocity using sound waves or laser beams directed externally on the skin. This allows physicians to analyze circulatory function in arteries and veins to detect abnormalities without requiring any incision or needles. Not only are such procedures painless and carry negligible risk, but patients also prefer them as they don't need to stay at the hospital. The convenience and safety aspects have made non-invasive diagnostics the preferred choice, especially for routine screening of cardiovascular health among older population. Various clinical studies have validated the diagnostic accuracy of non-invasive techniques for diseases like peripheral arterial disease when compared to invasive angiography.

With growing geriatric demographic worldwide suffering from increased risk of heart conditions, demand for periodic screening is on the rise. This has propelled the need for affordable, easy-to-use, and reliable non-invasive blood flow measurement devices that can be used even at point-of-care settings like physician clinics. Advancements in sensor and imaging technologies have further improved clinical efficacy of non-invasive systems, gaining more confidence of both patients and doctors alike. All these factors have strongly contributed towards increasing preference for non-invasive diagnostic procedures over the last few years, driving significant growth for the blood flow measurement devices market.

To learn more about this report, Request sample copy

Growing Prevalence of Cardiovascular Diseases

Cardiovascular diseases have emerged as the leading cause of mortality worldwide. According to various global burden of disease studies and reports published by the WHO, close to 18 million people succumb to some form of cardiovascular ailment every year accounting for over 30% of total global deaths. Some key reasons for growing prevalence of such conditions include rapidly aging population, rising levels of obesity, physical inactivity, unhealthy diet habits, and high stress levels associated with modern lifestyle. Genetic predisposition also plays an important role especially in developing countries where non-communicable chronic diseases were not very common until a few decades back.

The economic impact of cardiovascular diseases has been staggering too, accounting for over 10% of total global healthcare expenditure. With bulk of affected population now falling in productive middle age groups, loss of workplace productivity and associated indirect costs have become a major concern. Considering this huge lifelong economic and social burden, preventive diagnosis at early stages is a priority area. Regular monitoring of hemodynamics through the evaluation of blood flow patterns provides valuable insights for screening and management of cardiovascular health. As the incidence of cardiovascular diseases keep increasing rapidly across both developed and developing world driven by aging demographics and lifestyle changes, the need for diagnostic tools for screening large at-risk population has become more important than ever. This growing prevalence of heart conditions has significantly driven the demand for cost-effective, easy-to-use blood flow measurement devices that can aid primary physicians and cardiologists for routine monitoring as well as facilitate early detection before severity increases requiring intensive treatment.